SCHEMBL7958268

SCHEMBL7958268

[CH2]C=CCOC(=O)c1ccco1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.51
ALDH1A1 P00352 5/20 0.48
TSHR P16473 2/20 0.48
HTT P42858 1/20 0.48
MEN1 O00255 1/20 0.48
HSD17B10 Q99714 1/20 0.48
LMNA P02545 2/20 0.46
NPC1 O15118 1/20 0.46
MAPK1 P28482 1/20 0.45
KDM4E B2RXH2 1/20 0.45
MAPT P10636 1/20 0.45
HPGD P15428 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
GLA P06280 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Allyl 2-Furoate SCHEMBL1532489 0.83 CYP3A4 (0.56) KMT2AALDH1A1TSHRHTTMEN1
SCHEMBL28796965 0.81 KMT2A (0.59) KMT2AALDH1A1TSHRHTTMEN1
SCHEMBL4688815 0.79 KMT2A (0.60) KMT2AALDH1A1TSHRHTTMEN1
SCHEMBL11039202 0.77 ALDH1A1 (0.62) KMT2AALDH1A1TSHRHTTMEN1
SCHEMBL3146763 0.76 ALDH1A1 (0.57) KMT2AALDH1A1TSHRHTTMEN1
SCHEMBL27770727 0.75 KMT2A (0.60) KMT2AALDH1A1TSHRHTTMEN1
SCHEMBL790857 0.75 KMT2A (0.60) KMT2AALDH1A1TSHRHTTMEN1
SCHEMBL28689326 0.74 ALDH1A1 (0.52) KMT2AALDH1A1TSHRHTTMEN1
SCHEMBL15256939 0.74 ALDH1A1 (0.59) KMT2AALDH1A1TSHRHTTMEN1
SCHEMBL6830855 0.74 KMT2A (0.58) KMT2AALDH1A1TSHRHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310060-B1 FOR USE AS ANTIPROLIFERATIVE AGENT FOR USE AGAINST CANCER, PSORIASIS, RESTENOSIS, AUTOIMMUNE DISEASE, OR ATHEROSCLEROSIS WARNER-LAMBERT COMPANY 2001-10-30 US disclosed